Celldex Therapeutics, Inc. - Common Stock, par value $0.001 per share (CLDX)

CUSIP: 15117B202

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
67,629,115
Total 13F shares
46,338,765
Share change
+2,820,297
Total reported value
$1,790,195,856
Put/Call ratio
44%
Price per share
$38.64
Number of holders
170
Value change
+$97,400,922
Number of buys
87
Number of sells
69

Quarterly Holders Quick Answers

What is CUSIP 15117B202?
CUSIP 15117B202 identifies CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Celldex Therapeutics, Inc. - Common Stock, par value $0.001 per share (CLDX) as of Q4 2021

As of 31 Dec 2021, Celldex Therapeutics, Inc. - Common Stock, par value $0.001 per share (CLDX) was held by 170 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 46,338,765 shares. The largest 10 holders included FMR LLC, RTW INVESTMENTS, LP, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, Redmile Group, LLC, RA CAPITAL MANAGEMENT, L.P., EVENTIDE ASSET MANAGEMENT, LLC, and CITADEL ADVISORS LLC. This page lists 170 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.